Ebola Rapid Testing Platform Genalyte Inc. To Attend JP Morgan Health Care Conference
Finger Prick Test Delivers Complete Diagnostic Results in 15 Minutes
Biotech firm Genalyte – the company that has developed a ground-breaking finger-prick blood test and silicon chip panel for Ebola and more than a dozen other hemorrhagic diseases—announced today that its CEO Cary Gunn will be participating in the JP Morgan Healthcare Conference. Gunn will be attending the annual conference in San Francisco, January 12-15, 2015, where he will be discussing the Ebola diagnostics effort, in addition to more mainstream applications here in the US. In addition to testing for Ebola, the instrument can be installed in your doctor’s office or pharmacy where a patient’s entire diagnostic workup can be performed from a finger prick while your blood pressure is being taken.
Gunn will be available for meetings with members of the media covering the Ebola crisis or medical device testing innovation and the ongoing U.S. federal response to global health issues, domestically and abroad.
WHAT: Genalyte CEO attends leading national health care conference to participate in the dialogue surrounding the ongoing Ebola crisis.
WHERE: Westin St. Francis Hotel, San Francisco, CA
WHO: Genalyte CEO Cary Gunn
WHEN: January 12-15
CONTACT: media@genalyte.com
Help employers find you! Check out all the jobs and post your resume.
Biotech firm Genalyte – the company that has developed a ground-breaking finger-prick blood test and silicon chip panel for Ebola and more than a dozen other hemorrhagic diseases—announced today that its CEO Cary Gunn will be participating in the JP Morgan Healthcare Conference. Gunn will be attending the annual conference in San Francisco, January 12-15, 2015, where he will be discussing the Ebola diagnostics effort, in addition to more mainstream applications here in the US. In addition to testing for Ebola, the instrument can be installed in your doctor’s office or pharmacy where a patient’s entire diagnostic workup can be performed from a finger prick while your blood pressure is being taken.
Gunn will be available for meetings with members of the media covering the Ebola crisis or medical device testing innovation and the ongoing U.S. federal response to global health issues, domestically and abroad.
WHAT: Genalyte CEO attends leading national health care conference to participate in the dialogue surrounding the ongoing Ebola crisis.
WHERE: Westin St. Francis Hotel, San Francisco, CA
WHO: Genalyte CEO Cary Gunn
WHEN: January 12-15
CONTACT: media@genalyte.com
Help employers find you! Check out all the jobs and post your resume.